MX377300B - Terapia con células madre en patologías endometriales. - Google Patents

Terapia con células madre en patologías endometriales.

Info

Publication number
MX377300B
MX377300B MX2016016756A MX2016016756A MX377300B MX 377300 B MX377300 B MX 377300B MX 2016016756 A MX2016016756 A MX 2016016756A MX 2016016756 A MX2016016756 A MX 2016016756A MX 377300 B MX377300 B MX 377300B
Authority
MX
Mexico
Prior art keywords
endometrial
stem cell
cell therapy
pathologies
regeneration
Prior art date
Application number
MX2016016756A
Other languages
English (en)
Spanish (es)
Other versions
MX2016016756A (es
Inventor
Antonio Pellicer
Carlos Simón
Irene Cervello
Javier Santamaria
Original Assignee
Igenomix S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igenomix S L filed Critical Igenomix S L
Publication of MX2016016756A publication Critical patent/MX2016016756A/es
Publication of MX377300B publication Critical patent/MX377300B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
MX2016016756A 2014-06-17 2015-06-05 Terapia con células madre en patologías endometriales. MX377300B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
PCT/IB2015/001715 WO2015193737A1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Publications (2)

Publication Number Publication Date
MX2016016756A MX2016016756A (es) 2017-11-02
MX377300B true MX377300B (es) 2025-03-07

Family

ID=54329860

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016756A MX377300B (es) 2014-06-17 2015-06-05 Terapia con células madre en patologías endometriales.

Country Status (22)

Country Link
US (1) US11129851B2 (Direct)
EP (3) EP4012023B1 (Direct)
JP (2) JP6920062B2 (Direct)
CN (2) CN107073040A (Direct)
AU (1) AU2015275798B2 (Direct)
BR (1) BR112016029558A2 (Direct)
CA (1) CA2952559C (Direct)
CY (2) CY1122615T1 (Direct)
DK (2) DK3569697T3 (Direct)
ES (3) ES2983444T3 (Direct)
HR (3) HRP20220419T1 (Direct)
HU (3) HUE058328T2 (Direct)
LT (2) LT3569697T (Direct)
MX (1) MX377300B (Direct)
PL (3) PL3569697T3 (Direct)
PT (2) PT3569697T (Direct)
RS (3) RS59210B1 (Direct)
RU (1) RU2725006C2 (Direct)
SI (2) SI3158057T1 (Direct)
SM (3) SMT202200155T1 (Direct)
TR (1) TR201910410T4 (Direct)
WO (1) WO2015193737A1 (Direct)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
EP2859120B1 (en) 2012-06-06 2018-11-14 Fundació Institut de Recerca Biomèdica (IRB Barcelona) Method for the diagnosis and prognosis of lung cancer metastasis
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
ES2744244T3 (es) 2012-10-12 2020-02-24 Inbiomotion Sl Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata usando c-MAF
KR20150122786A (ko) 2013-03-15 2015-11-02 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) 암 전이의 진단, 예후 및 치료를 위한 방법
EP4012023B1 (en) 2014-06-17 2024-05-15 Asherman Therapy, S.L. Stem cell therapy in endometrial pathologies
AU2017281631B2 (en) * 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий
KR20230015832A (ko) 2021-07-23 2023-01-31 차의과학대학교 산학협력단 분리된 미토콘드리아를 유효성분으로 포함하는 아셔만 증후군 예방 또는 치료용 약학 조성물

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920700648A (ko) 1989-05-05 1992-08-10 오닐 크리스토퍼 가임성 향상
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
AU2001240096A1 (en) 2000-03-08 2001-09-17 Rebecca L. Dubowy Methods of diagnosing and monitoring endometrial glandular development
JP2004504275A (ja) 2000-05-24 2004-02-12 シエーリング　アクチエンゲゼルシャフト フィブリン−１の医薬用途
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
WO2004061074A2 (en) 2002-05-14 2004-07-22 The Board Of Trustees Of The Leland Stanford Junior University Endometrial genes in endometrial disorders
AU2003255355A1 (en) 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE10361928A1 (de) 2002-12-21 2004-07-01 Universität Leipzig Verfahren und Mittel zur Bestimmung von bestimmten Zuständen bzw. Veränderungen im Uterusepithel und im Epithel anderer Organe
WO2005018796A1 (en) 2003-08-21 2005-03-03 Pamgene B.V. Microarray support for bioprobe synthesis
EP1670902A4 (en) 2003-09-08 2008-05-07 Univ Texas METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG
CN1863905A (zh) 2003-09-08 2006-11-15 得克萨斯系统大学董事会 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物
DE602004028513D1 (de) 2003-12-23 2010-09-16 Mount Sinai Hospital Corp Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
WO2005117979A2 (en) 2004-05-28 2005-12-15 Applied Research Systems Ars Holding N.V. Use of il-17 in the treatment of fertility-related disorders
US20090111140A1 (en) * 2006-03-31 2009-04-30 Koninklijke Philips Electronics N.V. Systems and methods for cell measurement utilizing ultrashort t2*
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US8673850B2 (en) 2008-05-30 2014-03-18 Institut De Recherches Cliniques De Montreal PCSK9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
PT2768976T (pt) 2011-10-21 2018-04-05 Inst Nat Sante Rech Med Métodos para avaliar a receptividade endométrica de uma paciente após hiperestimulação ovárica controlada
AU2012346594B2 (en) 2011-11-30 2017-12-21 Agency For Science, Technology And Research GM1 ganglioside to Annexin V microparticle polypeptide ratio for biological monitoring
WO2014001244A1 (en) 2012-06-27 2014-01-03 Roche Diagnostics Gmbh MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
RU2515475C1 (ru) 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
WO2015166353A2 (en) 2014-03-21 2015-11-05 Equipo I. V. I. Investigacion S.L. Early detection of preeclampsia
EP4012023B1 (en) 2014-06-17 2024-05-15 Asherman Therapy, S.L. Stem cell therapy in endometrial pathologies

Also Published As

Publication number Publication date
CA2952559C (en) 2023-01-24
LT3569697T (lt) 2022-04-25
AU2015275798A1 (en) 2017-02-02
JP2020138984A (ja) 2020-09-03
HRP20220419T1 (hr) 2022-05-27
CA2952559A1 (en) 2015-12-23
SMT202400270T1 (it) 2024-07-09
CN107073040A (zh) 2017-08-18
AU2015275798B2 (en) 2021-03-25
EP4012023C0 (en) 2024-05-15
HUE058328T2 (hu) 2022-07-28
RU2017101147A3 (Direct) 2019-02-06
SMT202200155T1 (it) 2022-05-12
ES2736117T3 (es) 2019-12-26
RS59210B1 (sr) 2019-10-31
MX2016016756A (es) 2017-11-02
EP4012023A1 (en) 2022-06-15
EP3158057A1 (en) 2017-04-26
CY1125938T1 (el) 2024-02-16
TR201910410T4 (tr) 2019-08-21
EP3569697B1 (en) 2022-01-05
HRP20240798T1 (hr) 2024-09-27
EP4012023B1 (en) 2024-05-15
PT3158057T (pt) 2019-07-19
SI3158057T1 (sl) 2019-10-30
DK3569697T3 (da) 2022-04-04
EP3158057B1 (en) 2019-04-17
ES2983444T3 (es) 2024-10-23
US20170128492A1 (en) 2017-05-11
HUE044823T2 (hu) 2019-11-28
US11129851B2 (en) 2021-09-28
RS65719B1 (sr) 2024-08-30
RU2017101147A (ru) 2018-07-17
DK3158057T3 (da) 2019-07-29
RU2725006C2 (ru) 2020-06-29
BR112016029558A2 (pt) 2017-08-22
WO2015193737A1 (en) 2015-12-23
EP3569697A1 (en) 2019-11-20
PL4012023T3 (pl) 2024-09-02
CN116747241A (zh) 2023-09-15
JP2017522288A (ja) 2017-08-10
HUE067463T2 (hu) 2024-10-28
RS63093B1 (sr) 2022-04-29
PL3569697T3 (pl) 2022-07-04
ES2910306T3 (es) 2022-05-12
PT3569697T (pt) 2022-05-02
SI3569697T1 (sl) 2022-05-31
CY1122615T1 (el) 2021-03-12
EP3569697B8 (en) 2022-04-27
PL3158057T3 (pl) 2020-05-18
SMT201900400T1 (it) 2019-09-09
JP6920062B2 (ja) 2021-08-18
LT3158057T (lt) 2019-09-25
HRP20191240T1 (hr) 2019-11-01

Similar Documents

Publication Publication Date Title
MX377300B (es) Terapia con células madre en patologías endometriales.
PH12020500240A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
PH12018500714A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
EA201992610A1 (ru) Экспансия -t-клеток, композиции и способы их применения
SA519402159B1 (ar) بروتينات رابطة لمولد ضد مضادة لنيوروبيلين وطرق استخدامها
MX2021000708A (es) Anticuerpos de cadena pesada que se unen al cd19.
PH12017500803A1 (en) Anti-pd-1 antibodies
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
NZ737471A (en) Hydrophilic linkers for conjugation
MY196631A (en) Antibody Agents Specific for Human Cd19 and uses Thereof
PH12019502025A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
PH12020550964A1 (en) Heavy chain antibodies binding to cd22
MX390739B (es) Composicion de hueso comprimido y metodo para usar la misma.
MX359769B (es) Metodos para descelularizar huesos.
MX2018000897A (es) Celulas madre hematopoyeticas que expresan pd-l1 y usos.
HUE047540T2 (hu) Javított allogén dendritikus sejtek rák kezelésében történõ alkalmazásra
EP3185905A4 (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
MX390493B (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas
ZA202503388B (en) Semaglutide in medical therapy
NZ721835A (en) An osseointegrable device
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
MX2013004062A (es) Analogos de ciclosporina.
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
MX2019005821A (es) Proteínas de unión a antígenos anti-gitr y métodos de uso de las mismas.

Legal Events

Date Code Title Description
FG Grant or registration